ClinicalTrials.Veeva

Menu

MMP-7 Modulation by Short and Long Term Radiotherapy in Rectal Cancer Patients

R

Region Skane

Status

Completed

Conditions

Rectal Cancer

Treatments

Radiation: Neoadjuvant radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT03151759
LU155-01

Details and patient eligibility

About

To analyse the effects of radiation therapy on inflammation and matrilysin levels in rectal cancer patients.

Enrollment

77 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Adenocarcinoma of the rectum, ability to understand written and oral information, written consent.

Exclusion criteria

Colon cancer, benign tumors, impaired general condition of patient, declining to participate in the study, synchronous colonic tumors, logistical reasons, inability to understand written and/or oral information, previous pelvic irradiation, ongoing immunosuppressive therapy, diabetes with systemic complications.

Trial design

77 participants in 3 patient groups

No radiotherapy
Description:
Surgery only
25 Gray radiotherapy
Description:
Surgery after short term radiotherapy
Treatment:
Radiation: Neoadjuvant radiotherapy
50 Gray radiotherapy
Description:
Surgery after long term radiotherapy
Treatment:
Radiation: Neoadjuvant radiotherapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems